StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Lowered to $290 at Needham & Company
February 4, 2022 6:26 AM
Needham & Company analyst Ami Fadia lowered the price target on Biogen (NASDAQ: BIIB) to $290.00 (from $292.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Biogen (BIIB) PT Lowered to $230 at BofA Securities
February 4, 2022 5:50 AM
UPDATE: BMO Capital Downgrades Biogen (BIIB) to Market Perform
February 4, 2022 5:13 AM
Biogen (BIIB) PT Lowered to $285 at Oppenheimer
February 4, 2022 4:40 AM
Biogen (BIIB) PT Lowered to $235 at Barclays
February 4, 2022 4:37 AM
Biogen (BIIB) PT Lowered to $217 at Wolfe Research
February 4, 2022 3:57 AM
Form 10-K BIOGEN INC. For: Dec 31
February 3, 2022 5:27 PM
Biogen (BIIB) PT Lowered to $304 at Stifel
February 3, 2022 11:12 AM
Biogen (BIIB) Shares Fall as Guidance Comes In Below Consensus, Analyst Says Focus Remains on Aduhelm Coverage
February 3, 2022 10:37 AM
Biogen (BIIB) Misses Q4 EPS by 1c, ADUHELM Sales Just $1 Million ; Lowers FY Guidance
February 3, 2022 7:11 AM
